Registro:

Referencias:

• Oetting, A., Yen, P.M., New insights into thyroid hormone action (2007) Best Pract. Res. Clin. Endocrinol. Metab, 21 (2), pp. 193-208
• Zimmermann, M.B., Iodine deficiency (2009) Endocr. Rev, 30 (4), pp. 376-408
• Rubio, I.G., Medeiros-Neto, G., Mutations of the thyroglobulin gene and its relevance to thyroid disorders (2009) Curr. Opin. Endocrinol. Diabetes Obes, 16 (5), pp. 373-378
• Chiamolera, M.I., Wondisford, F.E., Minireview: Thyrotropinreleasing hormone and the thyroid hormone feedback mechanism (2009) Endocrinology, 150 (3), pp. 1091-1096
• Di Cosmo, C., Liao, X.H., Dumitrescu, A.M., Philp, N.J., Weiss, R.E., Refetoff, S., Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion (2010) J. Clin. Invest, 120 (9), pp. 3377-3388
• Mayerl, S., Visser, T.J., Darras, V.M., Horn, S., Heuer, H., Impact of Oatp1c1 deficiency on thyroid hormone metabolism and action in the mouse brain (2012) Endocrinology, 153 (3), pp. 1528-1537
• Gereben, B., Zavacki, A.M., Ribich, S., Kim, B.W., Huang, S.A., Simonides, W.S., Zeöld, A., Bianco, A.C., Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling (2008) Endocr. Rev, 29 (7), pp. 898-938
• Schweizer, U., Weitzel, J.M., Schomburg, L., Think globally: Act locally. New insights into the local regulation of thyroid hormone availability challenge long accepted dogmas (2008) Mol. Cell Endocrinol, 289 (1-2), pp. 1-9
• Hernandez, A., Martinez, M.E., Liao, X.H., Van Sande, J., Refetoff, S., Galton, V.A., St Germain, D.L., Type 3 deiodinase deficiency results in functional abnormalities at multiple levels of the thyroid axis (2007) Endocrinology, 148 (12), pp. 5680-5687
• Bassett, J.H., Harvey, C.B., Williams, G.R., Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions (2003) Mol. Cell. Endocrinol, 213, pp. 1-11
• Lazar, M.A., Thyroid hormone action: A binding contract (2003) J. Clin. Invest, 112, pp. 497-499
• Moeller, L.C., Broecker-Preuss, M., Transcriptional regulation by nonclassical action of thyroid hormone (2011) Thyroid Res, 4
• Harvey, C.B., Williams, G.R., Mechanism of thyroid hormone action (2002) Thyroid, 12, pp. 441-446
• Cheng, S.Y., Leonard, J.L., Davis, P.J., Molecular aspects of thyroid hormone actions (2010) Endocr. Rev, 31 (2), pp. 139-170
• Rosen, M.D., Chan, I.H., Privalsky, M.L., Mutant thyroid hormone receptors (TRs) isolated from distinct cancer types display distinct target gene specificities: A unique regulatory repertoire associated with two renal clear cell carcinomas (2011) Mol. Endocrinol, 25 (8), pp. 1311-1325
• Chan, I.H., Privalsky, M.L., A conserved lysine in the thyroid hormone receptor-alpha1 DNA-binding domain, mutated in hepatocel lular carcinoma, serves as a sensor for transcriptional regulation (2010) Mol. Cancer Res, 8 (1), pp. 15-23
• Liu, Y., Xia, X., Fondell, J.D., Yen, P.M., Thyroid hormoneregulated target genes have distinct patterns of coactivator recruitment and histone acetylation (2006) Mol. Endocrinol, 20 (3), pp. 483-490
• Williams, G.R., Neurodevelopmental and neurophysiological actions of thyroid hormone (2008) J. Neuroendocrinol, 20 (6), pp. 784-794
• Bernal, J., Thyroid hormone receptors in brain development and function (2007) Nat. Clin. Pract. Endocrinol. Metab, 3 (3), pp. 249-259
• Liu, Y.Y., Brent, G.A., Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation (2010) Trends Endocrinol. Metab, 21 (3), pp. 166-173
• Figueiredo, N.B., Cestari, S.H., Conde, S.J., Luvizotto, R.A., De Sibio, M.T., Perone, D., Katayama, M.L., Nogueira, C.R., Estrogen-responsive genes overlap with triiodothyronine-responsive genes in a breast carcinoma cell line (2014) Scientific World J
• Varga, F., Rumpler, M., Zoehrer, R., Turecek, C., Spitzer, S., Thaler, R., Paschalis, E.P., Klaushofer, K., T3 affects expression of collagen I and collagen cross-linking in bone cell cultures (2010) Biochem. Biophys. Res. Commun, 402 (2), pp. 18015-18018
• Cordeiro, A., Souza, L.L., Einicker-Lamas, M., Pazos-Moura, C.C., Non-classic thyroid hormone signalling involved in hepatic lipid metabolism (2013) J. Endocrinol, 216 (3), pp. R47-R57
• Potenza, M., Via, M.A., Yanagisawa, R.T., Excess thyroid hormone and carbohydrate metabolism (2009) Endocr. Pract, 15 (3), pp. 254-262
• Martínez-Sánchez, N., Alvarez, C.V., Fernø, J., Nogueiras, R., Diéguez, C., López, M., Hypothalamic effects of thyroid hormones on metabolism (2014) Best Pract. Res. Clin. Endocrinol. Metab, 28 (5), pp. 703-712
• Remaud, S., Gothié, J.D., Morvan-Dubois, G., Demeneix, B.A., Thyroid hormone signaling and adult neurogenesis in mammals (2014) Front Endocrinol, 5, p. 62
• Klecha, A.J., Genaro, A.M., Gorelik, G., Barreiro Arcos, M.L., Silberman, D.M., Schuman, M., Garcia, S.I., Cremaschi, G.A., Integrative study of hypothalamus-pituitary-thyroid-immune system interaction: Thyroid hormone-mediated modulation of lymphocyte activity through the protein kinase C signaling pathway (2006) J. Endocrinol, 189 (1), pp. 45-55
• Klecha, A.J., Barreiro Arcos, M.L., Frick, L., Genaro, A.M., Cremaschi, G., Immune-endocrine interactions in autoimmune thyroid diseases (2008) Neuroimmunomodulation, 15 (1), pp. 68-75
• Davis, P.J., Zhou, M., Davis, F.B., Lansing, L., Mousa, S.A., Lin, H.Y., Mini-review: Cell surface receptor for thyroid hormone and nongenomic regulation of ion fluxes in excitable cells (2010) Physiol. Behav, 99 (2), pp. 237-239
• Bergh, J.J., Lin, H.Y., Lansing, L., Mohamed, S.N., Davis, F.B., Mousa, S., Davis, P.J., Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen- activated protein kinase and induction of angiogenesis (2005) Endocrinology, 146 (7), pp. 2864-2871
• Davis, P.J., Lin, H.Y., Mousa, S.A., Luidens, M.K., Hercbergs, A.A., Wehling, M., Davis, F.B., Overlapping nongenomic and genomic actions of thyroid hormone and steroids (2011) Steroids, 76 (9), pp. 829-833
• Tang, H.Y., Lin, H.Y., Zhang, S., Davis, F.B., Davis, P.J., Thyroid hormone causes mitogen-activared protein kinase-dependent phosphorylation of the nuclear estrogen receptor (2004) Endocrinology, 145 (7), pp. 3265-3272
• Lin, H.Y., Tang, H.Y., Shih, A., Keating, T., Cao, G., Davis, P.J., Davis, F.B., Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic (2007) Steroids, 72 (2), pp. 180-187
• Lin, H.Y., Sun, M., Tang, H.Y., Lin, C., Luidens, M.K., Mousa, S.A., Incerpi, S., Davis, P.J., LThyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: Activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase (2009) Am. J. Physiol. Cell Physiol, 296 (5), pp. C980-C991
• Meng, R., Tang, H.Y., Westfall, J., London, D., Cao, J.H., Mousa, S.A., Luidens, M., Lin, H.Y., Crosstalk between integrin αvβ3 and estrogen receptor-α is involved in thyroid hormone-induced proliferation in human lung carcinoma cells (2011) PLoS One, 6 (11)
• Davis, P.J., Davis, F.B., Lin, H.Y., Mousa, S.A., Zhou, M., Luidens, M.K., Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor (2009) Am. J. Physiol. Endocrinol. Metab, 297 (6), pp. E1238-E1246
• Barreiro Arcos, M.L., Gorelik, G., Klecha, A., Genaro, A.M., Cremaschi, G.A., Thyroid hormones increase inducible nitric oxide synthase gene expression downstream from PKC-zeta in murine tumor T lymphocytes (2006) Am. J. Physiol. Cell Physiol, 291 (2), pp. C327-C336
• Barreiro Arcos, M.L., Sterle, H.A., Paulazo, M.A., Valli, E., Klecha, A.J., Isse, B., Pellizas, C.G., Cremaschi, G.A., Cooperative nongenomic and genomic actions on thyroid hormone mediated-modulation of T cell proliferation involve up-regulation of thyroid hormone receptor and inducible nitric oxide synthase expression (2011) J. Cell Physiol, 226 (12), pp. 3208-3218
• Cayrol, F., Díaz Flaqué, M.C., Fernando, T., Yang, S.N., Sterle, H.A., Bolontrade, M., Amorós, M., Cremaschi, G.A., Integrin αVβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells (2014) Blood, , in press
• Barreiro Arcos, M.L., Sterle, H.A., Vercelli, C., Valli, E., Cayrol, M.F., Klecha, A.J., Paulazo, M.A., Cremaschi, G.A., Induction of apoptosis in T lymphoma cells by long-term treatment with thyroxine involves PKCζ nitration by nitric oxide synthase (2013) Apoptosis, 18 (11), pp. 1376-1390
• Neri, A., Marmiroli, S., Tassone, P., Lombardi, L., Nobili, L., Verdelli, D., Civallero, M., Sacchi, S., The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines (2008) Leuk. Lymphoma, 49 (7), pp. 1374-1383
• Gibbs, P.E., Miralem, T., Lerner-Marmarosh, N., Tudor, C., Maines, M.D., Formation of ternary complex of human biliverdin reductase-protein kinase Cδ-ERK2 protein is essential for ERK2- mediated activation of Elk1 protein, nuclear factor-κB, and inducible nitric-oxidase synthase (iNOS) (2012) J. Biol. Chem, 287 (2), pp. 1066-1079
• Sterle, H.A., Valli, E., Cayrol, F., Paulazo, M.A., Martinel Lamas, D.J., Diaz Flaqué, M.C., Klecha, A.J., Barreiro Arcos, M.L., Thyroid status modulates T lymphoma growth via cell cycle regulatory proteins and angiogenesis (2014) J. Endocrinol, 222 (2), pp. 243-255
• Barrera-Hernandez, G., Park, K.S., Dace, A., Zhan, Q., Cheng, S.Y., Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclin-dependent kinase levels and activity (1999) Endocrinology, 140 (11), pp. 5267-5274
• Ledda-Columbano, G.M., Molotzu, F., Pibiri, M., Cossu, C., Perra, A., Columbano, A., Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes (2006) FASEB J, 20 (1), pp. 87-94
• Verga Falzacappa, C., Panacchia, L., Bucci, B., Stigliano, A., Cavallo, M.G., Brunetti, E., Toscano, V., Misiti, S., 3,5,3'- triiodothyronine (T3) is a survival factor for pancreatic beta-cells undergoing apoptosis (2006) J. Cell Physiol, 206 (2), pp. 309-321
• Zhang, B., Zhang, A., Zhou, X., Webb, P., He, W., Xia, X., Thyroid hormone analogue stimulates keratinocyte proliferation but inhibits cell differentiation in epidermis (2012) Int. J. Immunopathol. Pharmacol, 25 (4), pp. 859-869
• Mousa, S.A., Lin, H.Y., Tang, H.Y., Hercbergs, A., Luidens, M.K., Davis, P.J., Modulation of angiogenesis by thyroid hormone and hormone analogues: Implications for cancer management (2014) Angiogenesis, 17 (3), pp. 463-469
• Glinskii, A.B., Glinsky, G.V., Lin, H.Y., Tang, H.Y., Sun, M., Davis, F.B., Luidens, M.K., Davis, P.J., Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac) (2009) Cell Cycle, 8 (21), pp. 3562-3570
• Davis, P.J., Davis, F.B., Mousa, S.A., Luidens, M.K., Lin, H.Y., Membrane receptor for thyroid hormone: Physiologic and pharmacologic implications (2011) Annu. Rev. Pharmacol. Toxicol, 51, pp. 99-115
• Luidens, M.K., Mousa, S.A., Davis, F.B., Lin, H.Y., Davis, P.J., Thyroid hormone and angiogenesis (2010) Vascul. Pharmacol, 52 (3-4), pp. 142-145
• Ness, R.B., Grisso, J.A., Cottreau, C., Klapper, J., Vergona, R., Wheeler, J.E., Morgan, M., Schlesselman, J.J., Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer (2000) Epidemiology, 11 (2), pp. 111-117
• Ko, A.H., Wang, F., Holly, E.A., Pancreatic cancer and medical history in a population-based case-control study in the San Francisco Bay Area, California (2007) Cancer Causes Control, 18 (8), pp. 809-819
• Moeller, L.C., Führer, D., Thyroid hormone, thyroid hormone receptors and cancer: A clinical perspective (2013) Endocr. Relat. Cancer, 20 (2), pp. R19-R29
• Toms, S.A., Hercbergs, A., Liu, J., Kondo, S., Haqqi, T., Casey, G., Iwasaki, K., Barna, B.P., Antagonist effect of insulin- like growth factor I on protein kinase inhibitor-mediated apoptosis in human glioblastoma cells in association with bcl-2 and bcl-xL (1998) J. Neurosurg, 88 (5), pp. 884-889
• Cristofanilli, M., Yamamura, Y., Kau, S.W., Bevers, T., Strom, S., Patangan, M., Hsu, L., Hortobagyi, G.N., Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma (2005) Cancer, 103 (6), pp. 1122-1128
• Hercbergs, A., Spontaneous remission of cancer--a thyroid hormone dependent phenomenon? (1999) Anticancer Res, 19 (6 A), pp. 4839-4844
• Reddy, A., Dash, C., Leerapun, A., Mettler, T.A., Stadheim, L.M., Lazaridis, K.N., Roberts, R.O., Roberts, L.R., Hypothyroidism: A possible risk factor for liver cancer in patients with no known underlying cause of liver disease (2007) Clin. Gastroenterol Hepatol, 5 (1), pp. 118-123
• Kuijpens, J.L., Nyklíctek, I., Louwman, M.W., Weetman, T.A., Pop, V.J., Coebergh, J.W., Hypothyroidism might be related to breast cancer in post-menopausal women (2005) Thyroid, 15 (11), pp. 1253-1259
• Barreiro Arcos, M.L., Klecha, A.J., Genaro, A.M., Cremaschi, G.A., Immune System Modulation by Thyroid Axis Includes Direct Genomic and Nongenomic Actions of Thyroid Hormones on Immune Cells (2010) Immun., Endoc. & Metab. Agents in Med. Chem, 10, pp. 1-10
• Sánchez-Beato, M., Sánchez-Aguilera, A., Piris, M.A., Cell cycle deregulation in B-cell lymphomas (2003) Blood, 101, pp. 1220-1235
• Martínez-Iglesias, O., García-Silva, S., Regadera, J., Aranda, A., Hypothyroidism enhances tumor invasiveness and metastasis development (2009) PLoS One, 4 (7)
• Zukerberg, L.R., Yang, W.I., Arnold, A., Harris, N.L., Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry (1995) Am. J. Clin. Pathol, 103, pp. 756-760
• Kanavaros, P., Bai, M., Stefanaki, K., Poussias, G., Rontogianni, D., Zioga, E., Gorgoulis, V., Agnantis, N.J., Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas (2001) Histol. Histopathol, 16, pp. 377-386
• Mao, X., Orchard, G., Vonderheid, E.C., Novell, P.C., Bagot, M., Bensussan, A., Russell-Jones, R., Whittaker, S.J., Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis (2006) J. Invest. Dermatol, 126, pp. 1388-1395
• Doglioni, C., Chiarelli, C., Macro, E., Dei Tos, A.P., Meggiolaro, E., Dalla Palma, P., Barbareschi, M., Cyclin D3 expression in normal, reactive and neoplastic tissues (1998) J. Pathol, 185 (2), pp. 159-166
• Møller, M.B., Nielsen, O., Pedersen, N.T., Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features (2001) Am. J. Clin. Pathol, 115 (3), pp. 404-412
• Opavsky, R., Wang, S.H., Trikha, P., Raval, A., Huang, Y., Wu, Y.Z., Rodríguez, B., Plass, C., CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells (2007) PLoS Genet, 3, pp. 1757-1769
• Pérez de Castro, I.P., Malumbres, M., Santos, J., Pellicer, A., Fernández-Piqueras, J., Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas (1999) Carcinogenesis, 20, pp. 1675-1682
• Møller, M.B., Nielsen, O., Pedersen, N.T., Frequent alteration of MDM2 and p53 in the molecular progression of recurring non- Hodgkin's lymphoma (2002) Histopathology, 41 (4), pp. 322-330
• Verschuren, E.W., Hodgson, J.G., Gray, J.W., Kogan, S., Jones, N., Evan, G.I., The role of p53 in suppression of KSHV cyclininduced lymphomagenesis (2004) Cancer Res, 64 (2), pp. 581-589
• Karsunky, H., Guisen, C., Schmidt, T., Haas, K., Zevnik, B., Gau, E., Möröy, T., Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: Evidence for cooperation between cyclin E and Ras but not Myc (1999) Oncogene, 18 (54), pp. 7816-7824
• Martins, C.P., Berns, A., Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis (2002) EMBO J, 21, pp. 3739-3748
• Kang-Decker, N., Tong, C., Boussouar, F., Baker, D.J., Xu, W., Leontovich, A.A., Taylor, W.R., van Deursen, J.M., Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency (2004) Cancer Cell, 5 (2), pp. 177-189
• Alisi, A., Demori, I., Spagnuolo, S., Pierantozzi, E., Fugassa, E., Leoni, S., Thyroid status affects rat liver regeneration after partial hepatectomy by regulating cell cycle and apoptosis (2005) Cell. Physiol. Biochem, 15 (1-4), pp. 69-76
• Zhang, L., Cooper-Kuhn, C.M., Nannmark, U., Blomgren, K., Kuhn, H.G., Stimulatory effects of thyroid hormone on brain angiogenesis in vivo and in vitro (2010) J. Cereb. Blood Flow Metab, 30 (2), pp. 323-335
• Otto, T., Fandrey, J., Thyroid hormone induces hypoxia-inducible factor 1alpha gene expression through thyroid hormone receptor beta/retinoid x receptor alpha-dependent activation of hepatic leukemia factor (2008) Endocrinology, 149 (5), pp. 2241-2250
• Davis, F.B., Mousa, S.A., O'Connor, L., Mohamed, S., Lin, H.Y., Cao, H.J., Davis, P.J., Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface (2004) Circ. Res, 94 (11), pp. 1500-1506
• Pinto, M., Soares, P., Ribatti, D., Thyroid hormone as a regulator of tumor induced angiogenesis (2011) Cancer Lett, 301 (2), pp. 119-126

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------